Results 141 to 150 of about 3,887,212 (164)

Combined radioligand therapy and immunotherapy for cancer: research advances and translational challenges. [PDF]

Front Pharmacol
Wang S, Tang S, Tang S, Wang C, Wang J, Yang Y, Yang Y, Liu C, Fu J, Zhou H.   +9 more
europepmc   +1 more source

Controversies in NEN: An ENETS position statement on the interchangeability of somatostatin receptor PET tracers. [PDF]

J Neuroendocrinol
Deroose CM, Ambrosini V, Hofland J, Kaltsas G, Kjaer A, Lamarca A, Sowa-Staszczak A, Janson ET, Fazio N.   +8 more
europepmc   +1 more source

My Life as a "Theranostician": A commentary on the evolution of theranostics. [PDF]

Npj Imaging
Hicks RJ.
europepmc   +1 more source

Systemic therapy for gastroenteropancreatic neuroendocrine neoplasms: current landscape and future directions. [PDF]

Ther Adv Med Oncol
So E, Morizane C, Okusaka T.
europepmc   +1 more source

Artificial intelligence across oncologic theranostics: evidence for patient stratification, dosimetry, and adaptive radiopharmaceutical therapy. [PDF]

Front Nucl Med
Banala M, Ezuddin S, Foley M, Kuker R.
europepmc   +1 more source

Therapy for aggressive pituitary tumors and carcinomas. [PDF]

Rev Endocr Metab Disord
Ilie MD, Lamback E, Gadelha M, Raverot G.   +3 more
europepmc   +1 more source

Peptide receptor radionuclide therapy in neuroendocrine tumours: advances, combination strategies, and future directions. [PDF]

Eur J Nucl Med Mol Imaging
Virgolini IJ, Di Santo G, Santo G.
europepmc   +1 more source